Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options
has been studied and deployed. Healthcare providers have multiple treatment approaches …

The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …

Abstract Purpose of Review Rapidly evolving treatment paradigms of coronavirus disease
2019 (COVID-19) introduce challenges for clinicians to keep up with the pace of published …

On December 8, 2020, a 91-year-old woman made history as the first person to receive the
COVID-19 vaccine in the United Kingdom. Worldwide vaccination coverage will take time …

The COVID-19 pandemic required rapid response to the needs of critically ill patients, and
one of the solutions was re-purposing of drugs with wide spectrum of antiviral action for …

Severe COVID-19 is a biphasic illness, with an initial viral replication phase, followed by a
cascade of inflammatory events. Progression to severe disease is predominantly a function …

Background: The recent COVID-19 pandemic sweeping the globe has caused great concern
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …

COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020.
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …

Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …